Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -293,586 | -218,374 | -146,529 | -212,526 | -158,809 |
| Depreciation Amortization | 8,248 | 5,934 | 3,471 | 9,494 | 8,826 |
| Income taxes - deferred | -782 | -493 | -186 | -6,119 | -3,062 |
| Accounts receivable | -7,727 | -5,952 | -3,575 | -1,623 | -67 |
| Accounts payable and accrued liabilities | 8,782 | 5,655 | -3,439 | 3,578 | 7,233 |
| Other Working Capital | 4,550 | -595 | -1,232 | 6,144 | 10,552 |
| Other Operating Activity | 143,541 | 122,682 | 107,181 | 89,285 | 68,538 |
| Operating Cash Flow | $-136,974 | $-91,143 | $-44,309 | $-111,767 | $-66,789 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -26,622 | -24,528 | -22,268 | -11,195 | -15,748 |
| Net Acquisitions | -1,162 | N/A | N/A | -10,000 | N/A |
| Investing Cash Flow | $-27,784 | $-24,528 | $-22,268 | $-21,195 | $-15,748 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 18,858 | 18,858 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | 263,384 | 39,435 |
| Debt Repayment | N/A | N/A | -1,178 | N/A | N/A |
| Common Stock Issued | 24,558 | 1,206 | 81 | 83,819 | 71,784 |
| Other Financing Activity | -2,441 | -1,658 | 0 | -21,205 | 131,484 |
| Financing Cash Flow | $40,975 | $18,406 | $-1,097 | $325,998 | $242,703 |
| Exchange Rate Effect | 156 | 62 | 57 | -135 | -154 |
| Beginning Cash Position | 213,330 | 213,330 | 213,330 | 20,429 | 20,429 |
| End Cash Position | 89,391 | 116,127 | 145,713 | 213,330 | 180,441 |
| Net Cash Flow | $-123,939 | $-97,203 | $-67,617 | $192,901 | $160,012 |
| Free Cash Flow | |||||
| Operating Cash Flow | -136,974 | -91,143 | -44,309 | -111,767 | -66,789 |
| Capital Expenditure | -26,622 | -24,528 | -22,268 | -11,195 | -15,748 |
| Free Cash Flow | -163,596 | -115,671 | -66,577 | -122,962 | -82,537 |